Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator gene (CFTR) that result in diminished quantity and/or function of the CFTR anion channel. F508del-CFTR, the most common CF-causing mutation (found in ∼90% of patients), causes severe processing and trafficking...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
European Respiratory Society
2019-06-01
|
| Saila: | ERJ Open Research |
| Sarrera elektronikoa: | http://openres.ersjournals.com/content/5/2/00082-2019.full |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
